The Mental Health Assessment and Dynamic Referral for Oncology (MHADRO)

肿瘤学心理健康评估和动态转诊 (MHADRO)

基本信息

批准号：
7156131
负责人：
Edwin D Boudreaux
金额：
$ 14.35万
依托单位：
POLARIS HEALTH DIRECTIONS, INC.
依托单位国家：
美国
项目类别：
财政年份：
2006
资助国家：
美国
起止时间：
2006-09-20 至 2008-03-19
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7156131
关键词：
automated data processing behavioral /social science research tag clinical research computer assisted medical decision making computer human interaction computer system design /evaluation data collection methodology /evaluation health behavior health care referral /consultation human subject mass screening medical records mental disorder diagnosis oncology patient oriented research psychological aspect of cancer psychometrics questionnaires

项目摘要

DESCRIPTION (provided by applicant): According to the American Cancer Society, approximately 1.3 million people are diagnosed with cancer each year, with the annual cost of treating cancer exceeding $60.9 billion. Mental health and psychosocial factors can be strongly associated with treatment adherence, treatment response, and quality of life among cancer patients. Too often, however, these aspects of the cancer experience are poorly recognized and under-treated. The Mental Health Assessment and Dynamic Referral for Oncology (MHADRO) will provide for an automated assessment and ongoing monitoring of mental health and psychosocial symptoms, such as depression, anxiety, and PTSD; cancer-related symptoms, such as pain and fatigue; quality of life; and adherence with treatment recommendations. The MHADRO's individualized summary reports will help oncology treatment providers to decide whether and how to intervene when clinically elevated mental health symptoms are present or when a patient reports a desire for treatment or support. Moreover, the dynamic referral capacity of the MHADRO will actually facilitate linkage with mental health treatment providers. Patients who choose the dynamic referral will have their summary report, a signed authorization to release information, and their personal contact information (e.g., telephone number, address) electronically transmitted to a credentialed mental health provider, who will then be responsible for contacting the patient to discuss treatment options. This process will utilize secure, HIPAA-compliant transmittal technologies. In addition, the MHADRO will allow mental health providers and community based psychosocial support (CBPS) programs to better target their services to those who need it most and to evaluate the effectiveness of their programs. Finally, hierarchical linear modeling techniques will be applied to longitudinal data (collected during Phase II) to establish predictive models for expected treatment response (ETR) to mental health interventions and for treatment non-adherence. This will allow the MHADRO to function as a "learning system." Phase I specific aims are: (1) Construct the patient assessment and support informant questionnaires; (2) Automate the administration of the questionnaires; (3) Design and automate the generation of individual patient summary reports; (4) Design and create the dynamic referral capability; (5) Establish preliminary cancer patient norms and psychometric properties for the MHADRO scales; and, (6) Evaluate end-user acceptance (medical, mental health, patient, support informant). During Phase II, monitoring reports indicating changes/trends in the patient's psychosocial condition over time will be automated; software will be developed to produce aggregate program level reports; ETR algorithms will be derived; predictive models for nonadherence will be developed; system implementation materials will be written; and a randomized, controlled trial will be completed to establish the MHADRO's efficacy in identifying clinically relevant mental health issues and facilitating appropriate treatment.

描述（由申请人提供）：根据美国癌症协会的说法，每年约有130万人被诊断出患有癌症，每年治疗癌症的成本超过6009亿美元。心理健康和社会心理因素可以与癌症患者的治疗依从性，治疗反应和生活质量密切相关。然而，癌症经验的这些方面经常被众所周知和治疗不足。心理健康评估和动态肿瘤学转诊（MHADRO）将提供对心理健康和社会心理症状（例如抑郁，焦虑和PTSD）的自动评估和持续监测；与癌症有关的症状，例如疼痛和疲劳；生活质量；并遵守治疗建议。 Mhadro的个性化摘要报告将有助于肿瘤治疗提供者在存在临床心理健康症状时是否以及如何干预，或者当患者报告对治疗或支持的渴望时如何进行干预。此外，Mhadro的动态转诊能力实际上将促进与心理健康治疗提供者的联系。选择动态推荐的患者将有摘要报告，签署的授权释放信息的授权以及他们的个人联系信息（例如，电话号码，地址）电子传播给有资格的心理健康提供者，然后将负责与患者联系以讨论治疗方案。此过程将利用安全的，符合HIPAA的透射技术。此外，Mhadro将允许心理健康提供者和基于社区的社会心理支持（CBP）计划将其服务更好地针对最需要的人并评估其计划的有效性。最后，层次线性建模技术将应用于纵向数据（在II阶段期间收集），以建立预期治疗反应（ETR）对心理健康干预措施和治疗不遵守的预测模型。这将使Mhadro充当“学习系统”。第一阶段的特定目的是：（1）构建患者评估和支持线人问卷；（2）自动化问卷的管理；（3）设计和自动化单个患者摘要报告的生成；（4）设计并创建动态推荐能力；（5）建立Mhadro量表的初步癌症患者规范和心理测量特性；（6）评估最终用户接受（医疗，心理健康，患者，支持者）。在第二阶段，监测报告表明随着时间的推移，随着时间的推移，患者心理社会状况的变化/趋势将被自动化；将开发软件以生成汇总程序级报告；将得出ETR算法；将开发非依从性的预测模型；系统实施材料将编写；并且将完成一项随机对照试验，以确定Mhadro在识别临床相关的心理健康问题并促进适当治疗方面的功效。